Headache Impact Test (HIT-6)

Headache Impact Test (HIT-6)

Cerebral Torque

HIT-6 is a reliable and valid tool for discriminating headache impact across episodic and chronic migraine. It was designed to provide a global measure of adverse headache impact and was developed to use in screening and monitoring patients with headaches in both clinical practice and clinical research.

When you have headaches, how often is the pain severe?

Never
Rarely
Sometimes
Very often
Always

How often do headaches limit your ability to do usual daily activities including household work, work, school, or social activities?

Never
Rarely
Sometimes
Very often
Always

When you have a headache, how often do you wish you could lie down?

Never
Rarely
Sometimes
Very often
Always

In the past 4 weeks, how often have you felt too tired to do work or daily activities because of your headaches?

Never
Rarely
Sometimes
Very often
Always

In the past 4 weeks, how often have you felt fed up or irritated because of your headaches?

Never
Rarely
Sometimes
Very often
Always

In the past 4 weeks, how often did headaches limit your ability to concentrate on work or daily activities?

Never
Rarely
Sometimes
Very often
Always

 

 

The four headache impact severity categories are little or no impact (49 or less), some impact (50–55), substantial impact (56–59), and severe impact (60–78). 

Reference: Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6TM) across episodic and chronic migraine. Cephalalgia. 2011;31(3):357-367. doi:10.1177/0333102410379890.

Back to blog
  • A Breakthrough on the Horizon: PACAP-Targeting Antibodies Offer New Promise for Migraine Prevention

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

  • New Study Maps Migraine Symptoms Across Attack Phases

    New Study Maps Migraine Symptoms Across Attack ...

    Cerebral Torque

    Symptom Pre-headache* Headache* Post-headache* Interictal* Pooled %** Notes Head pain 50% 100% 28% 5% 100% Only universally reported symptom; defining feature of headache phase Light sensitivity 75% 80% 30% 13%...

    New Study Maps Migraine Symptoms Across Attack ...

    Cerebral Torque

    Symptom Pre-headache* Headache* Post-headache* Interictal* Pooled %** Notes Head pain 50% 100% 28% 5% 100% Only universally reported symptom; defining feature of headache phase Light sensitivity 75% 80% 30% 13%...

  • White Matter Lesions in Migraine Patients: What You Need to Know

    White Matter Lesions in Migraine Patients: What...

    Cerebral Torque

    Discover what white matter lesions mean for migraine patients. This guide explores the latest research on the relationship between migraine and brain changes, offering insights into prevalence, potential causes, and...

    White Matter Lesions in Migraine Patients: What...

    Cerebral Torque

    Discover what white matter lesions mean for migraine patients. This guide explores the latest research on the relationship between migraine and brain changes, offering insights into prevalence, potential causes, and...

  • Gepant Adverse Events Chart

    Gepant Adverse Events Chart

    Cerebral Torque

    A comprehensive analysis of real-world data has uncovered important insights into the safety profiles of gepant medications used for migraine treatment. The study, which examined adverse events reported in the...

    Gepant Adverse Events Chart

    Cerebral Torque

    A comprehensive analysis of real-world data has uncovered important insights into the safety profiles of gepant medications used for migraine treatment. The study, which examined adverse events reported in the...

1 4
View all